ADA-friendly PDF: Treatment Guidelines: Adjuvant Abemaciclib for Early-Stage, Hormone-Receptor-Positive Breast Cancer

Adjuvant Abemaciclib for Early-Stage, Hormone-Receptor-Positive Breast Cancer

Back to Symposium

The Breast Oncology Center at Dana-Farber Brigham Cancer Center held multidisciplinary meetings to discuss recommendations regarding the use of adjuvant abemaciclib in patients with early-stage, hormone-receptor-positive breast cancer.